Rigel Pharmaceuticals Inc (RIGL) — Strategic Asset Allocation Index
Rigel Pharmaceuticals Inc (RIGL) has a Strategic Asset Allocation Index of 31.5% as of March 2022. Strategic assets (PP&E of $2.14 Million plus long-term investments of $-) total $2.14 Million, measured against net assets of $6.80 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Rigel Pharmaceuticals Inc Strategic Asset Allocation Index (2000–2021)
This chart shows how Rigel Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of March 2022, the index stands at 31.5%, representing strategic assets of $2.14 Million against net assets of $6.80 Million USD. Explore RIGL cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Rigel Pharmaceuticals Inc (2000–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Rigel Pharmaceuticals Inc from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see RIGL company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 39.1% | $11.89 Million | $11.89 Million | $- | $30.37 Million | ▲ +31.3 pp |
| 2020 | 7.9% | $2.68 Million | $2.68 Million | $- | $34.03 Million | ▲ +3.9 pp |
| 2019 | 4.0% | $2.16 Million | $2.16 Million | $- | $53.81 Million | ▲ +2.7 pp |
| 2018 | 1.3% | $1.39 Million | $1.39 Million | $- | $109.88 Million | ▲ +0.4 pp |
| 2017 | 0.9% | $875.00K | $875.00K | $- | $100.65 Million | ▼ -1.2 pp |
| 2016 | 2.1% | $1.16 Million | $1.16 Million | $- | $55.03 Million | ▲ +0.3 pp |
| 2015 | 1.8% | $1.61 Million | $1.61 Million | $- | $91.38 Million | ▼ -0.2 pp |
| 2014 | 2.0% | $2.51 Million | $2.51 Million | $- | $128.25 Million | ▼ -0.2 pp |
| 2013 | 2.1% | $4.46 Million | $4.46 Million | $- | $208.25 Million | ▲ +0.1 pp |
| 2012 | 2.0% | $5.83 Million | $5.83 Million | $- | $289.10 Million | ▼ -0.1 pp |
| 2011 | 2.1% | $4.88 Million | $4.88 Million | $- | $236.15 Million | ▼ -0.7 pp |
| 2010 | 2.7% | $4.53 Million | $4.53 Million | $- | $166.13 Million | ▲ +0.6 pp |
| 2009 | 2.1% | $2.29 Million | $2.29 Million | $- | $109.87 Million | ▼ -1.3 pp |
| 2008 | 3.4% | $3.57 Million | $3.57 Million | $- | $104.17 Million | ▲ +0.3 pp |
| 2007 | 3.1% | $2.56 Million | $2.56 Million | $- | $82.18 Million | ▼ -0.3 pp |
| 2006 | 3.4% | $2.98 Million | $2.98 Million | $- | $87.23 Million | ▲ +0.2 pp |
| 2005 | 3.2% | $3.46 Million | $3.46 Million | $- | $108.59 Million | ▼ -2.2 pp |
| 2004 | 5.4% | $2.81 Million | $2.81 Million | $- | $52.30 Million | ▼ -3.5 pp |
| 2003 | 8.9% | $3.54 Million | $3.54 Million | $- | $39.97 Million | ▼ -11.6 pp |
| 2002 | 20.5% | $5.21 Million | $5.21 Million | $- | $25.44 Million | ▼ -8.7 pp |
| 2001 | 29.2% | $8.44 Million | $8.44 Million | $- | $28.94 Million | ▲ +10.1 pp |
| 2000 | 19.1% | $9.34 Million | $9.34 Million | $- | $49.01 Million | — |